Financials
- Market Capitalization 251.16 M
- Employee 35
- Founded 2008
- CEO N/A
- Website www.inhibikase.com
- Headquarter Delaware, United States
- FIGI BBG005TP2339
- Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
-4.18
市销率
53.93
Related tickers
| # | 姓名 | 价格 | 24小时 % | 7天 % | 一个月 % | 一年 % | 市值 | 最近7天 | |
|---|---|---|---|---|---|---|---|---|---|
| 3359 | NAUT Nautilus Biotechnology, Inc. - Common Stock | 2.03 USD | -6.45% | +10.93% | +100.99% | +123.08% | 258.33 M USD | ||
| 3368 | IPSC Century Therapeutics, Inc. - Common Stock | 1.40 USD | -2.78% | +2.94% | -28.57% | +154.55% | 253.51 M USD | ||
| 3389 | RCKT Rocket Pharmaceuticals, Inc. - Common Stock | 2.26 USD | -8.87% | -9.24% | -31.31% | -42.35% | 248.09 M USD | ||
| 3394 | ACIU AC Immune SA - Common Stock | 2.42 USD | -1.22% | -4.35% | -11.36% | -29.45% | 246.22 M USD |